-
1
-
-
0034598111
-
Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis
-
10.1136/bmj.321.7273.1371 1:STN:280:DC%2BD3M7hsFSrsg%3D%3D 11099280
-
J Geddes N Freemantle P Farrison P Bebbington 2000 Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis BMJ 321 1371 1376 10.1136/bmj.321.7273.1371 1:STN:280:DC%2BD3M7hsFSrsg%3D%3D 11099280
-
(2000)
BMJ
, vol.321
, pp. 1371-1376
-
-
Geddes, J.1
Freemantle, N.2
Farrison, P.3
Bebbington, P.4
-
2
-
-
0038582771
-
New generation antipsychotics versus low-potency conventional antipsychotics: A systematic review and meta-analysis
-
DOI 10.1016/S0140-6736(03)13306-5
-
S Leucht K Wahlbeck J Hamann W Kissling 2003 New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis Lancet 361 1581 1589 10.1016/S0140-6736(03)13306-5 1:CAS:528:DC%2BD3sXjs1Wltbw%3D 12747876 (Pubitemid 36578993)
-
(2003)
Lancet
, vol.361
, Issue.9369
, pp. 1581-1589
-
-
Leucht, S.1
Wahlbeck, K.2
Hamann, J.3
Kissling, W.4
-
3
-
-
0038653525
-
A meta-analysis of the efficacy of second-generation antipsychotics
-
DOI 10.1001/archpsyc.60.6.553
-
JM Davis N Chen ID Glick 2003 A meta-analysis of the efficacy of second-generation antipsychotics Arc Gen Psychiatry 60 553 564 10.1001/archpsyc.60.6.553 1:CAS:528:DC%2BD3sXltlKhtrc%3D (Pubitemid 36682312)
-
(2003)
Archives of General Psychiatry
, vol.60
, Issue.6
, pp. 553-564
-
-
Davis, J.M.1
Chen, N.2
Glick, I.D.3
-
4
-
-
0345293130
-
Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia: A Randomized Controlled Trial
-
DOI 10.1001/jama.290.20.2693
-
R Rosenheck D Perlick S Bingham W Liu-Mares J Collins S Warren D Leslie E Allan EC Campbell S Caroff J Corwin L Davis R Douyon L Dunn D Evans E Frecska J Grabowski D Graeber L Herz K Kwon W Lawson F Mena J Sheikh D Smelson V Smith-Gamble 2003 Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia JAMA 290 2693 2702 10.1001/jama.290.20.2693 1:CAS:528:DC%2BD3sXpsVaktLg%3D 14645311 (Pubitemid 37475597)
-
(2003)
Journal of the American Medical Association
, vol.290
, Issue.20
, pp. 2693-2702
-
-
Rosenheck, R.1
Perlick, D.2
Bingham, S.3
Liu-Mares, W.4
Collins, J.5
Warren, S.6
Leslie, D.7
Allan, E.8
Campbell, E.C.9
Caroff, S.10
Corwin, J.11
Davis, L.12
Douyon, R.13
Dunn, L.14
Evans, D.15
Frecska, E.16
Grabowski, J.17
Graeber, D.18
Herz, L.19
Kwon, K.20
Lawson, W.21
Mena, F.22
Sheikh, J.23
Smelson, D.24
Smith-Gamble, V.25
more..
-
5
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
DOI 10.1056/NEJMoa051688
-
JA Lieberman TS Stroup JP McEvoy MS Swartz RA Rosenheck DO Perkins RSE Keefe SM Davis CE Davis BD Lebowitz J Severe JK Hsiao 2005 Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 1209 1223 10.1056/NEJMoa051688 1:CAS:528:DC%2BD2MXhtVeltL%2FN 16172203 (Pubitemid 41345943)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.12
, pp. 1209-1223
-
-
Lieberman, J.A.1
Scott Stroup, T.2
McEvoy, J.P.3
Swartz, M.S.4
Rosenheck, R.A.5
Perkins, D.O.6
Keefe, R.S.E.7
Davis, S.M.8
Davis, C.E.9
Lebowitz, B.D.10
Severe, J.11
Hsiao, J.K.12
-
6
-
-
33749321169
-
Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
-
DOI 10.1001/archpsyc.63.10.1079
-
PB Jones TRE Barnes L Davies G Dunn H Lloyd KP Hayhurst RM Murray A Markwick SW Lewis 2006 Randomized controlled trial of the effect on quality of life of second- vs. first-generation antipsychotic drugs in schizophrenia Arch Gen Psychiatry 63 1079 1087 10.1001/archpsyc.63.10.1079 1:CAS:528: DC%2BD28XhtFKhtrzP 17015810 (Pubitemid 44498387)
-
(2006)
Archives of General Psychiatry
, vol.63
, Issue.10
, pp. 1079-1087
-
-
Jones, P.B.1
Barnes, T.R.E.2
Davies, L.3
Dunn, G.4
Lloyd, H.5
Hayhurst, K.P.6
Murray, R.M.7
Markwick, A.8
Lewis, S.W.9
-
7
-
-
33745875644
-
Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: Comparison with officially recommended doses
-
1:CAS:528:DC%2BD28XnsVamsrs%3D 16848649
-
GWK Hugenholtz ER Heerdink JJ Stolker WEE Meijer ACG Egberts WA Nolen 2006 Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses J Clin Psychiatry 67 897 903 1:CAS:528:DC%2BD28XnsVamsrs%3D 16848649
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 897-903
-
-
Hugenholtz, G.W.K.1
Heerdink, E.R.2
Stolker, J.J.3
Meijer, W.E.E.4
Egberts, A.C.G.5
Nolen, W.A.6
-
8
-
-
33645105012
-
Serotonin-dopamine antagonists (atypical or second-generation antipsychotics)
-
J.B. Sadock V.A. Sadock (eds). Lippincott Williams & Wilkins Philadelphia
-
van Kammen DP, Marder SR (2005) Serotonin-dopamine antagonists (atypical or second-generation antipsychotics). In: Sadock JB, Sadock VA (eds) Kaplan & Sadock's comprehensive textbook of psychiatry. Lippincott Williams & Wilkins, Philadelphia, pp 2914-2938
-
(2005)
Kaplan & Sadock's Comprehensive Textbook of Psychiatry
, pp. 2914-2938
-
-
Van Kammen, D.P.1
Marder, S.R.2
-
9
-
-
33747021407
-
2A receptor blockade
-
10.2174/187152706777950693 1:CAS:528:DC%2BD28XnvFykt7g%3D
-
2A receptor blockade CNS & Neurological Disorders-Drug Targets 5 445 445 10.2174/187152706777950693 1:CAS:528:DC%2BD28XnvFykt7g%3D
-
(2006)
CNS & Neurological Disorders-Drug Targets
, vol.5
, pp. 445-445
-
-
Wood, M.D.1
Scott, C.2
Clarke, K.3
Cato, K.J.4
Patel, N.5
Heath, J.6
Worby, A.7
Gordon, L.8
Campbell, L.9
Riley, G.10
Davis, C.H.11
Gribble, A.12
Jones, D.N.C.13
-
10
-
-
61349156022
-
The use and potential abuse of anticholinergic antiparkinson drugs in Norway. A pharmacoepidemiological study
-
10.1111/j.1365-2125.2008.03342.x 19094158
-
P Gjerden JG Bramness L Slørdal 2008 The use and potential abuse of anticholinergic antiparkinson drugs in Norway. A pharmacoepidemiological study Br J Clin Pharmacol 67 2 228 233 10.1111/j.1365-2125.2008.03342.x 19094158
-
(2008)
Br J Clin Pharmacol
, vol.67
, Issue.2
, pp. 228-233
-
-
Gjerden, P.1
Bramness, J.G.2
Slørdal, L.3
-
11
-
-
34447320942
-
The Norwegian Prescription Database (NorPD): New register for pharmacoepidemiological research covering a whole nation
-
K Furu H Strøm M Rønning S Skurtveit A Engedal A Tverdal 2005 The Norwegian Prescription Database (NorPD): new register for pharmacoepidemiological research covering a whole nation Pharmacoepidemiol Drug Saf 14 Suppl 2 S48
-
(2005)
Pharmacoepidemiol Drug Saf
, vol.14
, Issue.SUPPL 2
, pp. 48
-
-
Furu, K.1
Strøm, H.2
Rønning, M.3
Skurtveit, S.4
Engedal, A.5
Tverdal, A.6
-
12
-
-
0004100812
-
-
WHO Collaborating Centre for Drug Statistics Methodology. WHO Oslo
-
WHO Collaborating Centre for Drug Statistics Methodology (2005) Guidelines for ATC classification and DDD assignment. WHO, Oslo
-
(2005)
Guidelines for ATC Classification and DDD Assignment
-
-
-
13
-
-
0038014053
-
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
-
10.1038/sj.npp.1300027 1:CAS:528:DC%2BD3sXhslyjt7Y%3D 12629531
-
WK Kroeze SJ Hufheisen BA Popadak SM Renock S Steinberg P Ernsberger K Jayathilake HY Meltzer BL Roth 2003 H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs Neuropsychopharmacology 28 519 526 10.1038/sj.npp.1300027 1:CAS:528: DC%2BD3sXhslyjt7Y%3D 12629531
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 519-526
-
-
Kroeze, W.K.1
Hufheisen, S.J.2
Popadak, B.A.3
Renock, S.M.4
Steinberg, S.5
Ernsberger, P.6
Jayathilake, K.7
Meltzer, H.Y.8
Roth, B.L.9
-
14
-
-
39949085594
-
World psychiatric association pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
-
10.1016/j.schres.2007.11.033
-
R Tandon RH Belmaker WF Gattaz JJ Lopez-Ibor Jr A Okasha B Singh DJ Stein J-P Olie WW Fleishhacker H-J Moeller 2008 World psychiatric association pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia Schiz Res 100 20 38 10.1016/j.schres.2007.11.033
-
(2008)
Schiz Res
, vol.100
, pp. 20-38
-
-
Tandon, R.1
Belmaker, R.H.2
Gattaz, W.F.3
Lopez-Ibor Jr, J.J.4
Okasha, A.5
Singh, B.6
Stein, D.J.7
Olie, J.-P.8
Fleishhacker, W.W.9
Moeller, H.-J.10
-
15
-
-
0025268175
-
Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on aspects of mental illness
-
Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on aspects of mental illness (1990) Br J Psychiatry 156:412
-
(1990)
Br J Psychiatry
, vol.156
, pp. 412
-
-
-
16
-
-
64549134700
-
Effect of warnings in a medical journal on the use of orphenadrine
-
10.1111/j.1365-2753.2007.00912.x 18462287
-
P Gjerden JG Bramness L Slørdal 2008 Effect of warnings in a medical journal on the use of orphenadrine J Eval Clin Pract 14 615 617 10.1111/j.1365-2753.2007.00912.x 18462287
-
(2008)
J Eval Clin Pract
, vol.14
, pp. 615-617
-
-
Gjerden, P.1
Bramness, J.G.2
Slørdal, L.3
-
17
-
-
0034919926
-
Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America
-
DOI 10.1097/00004714-200108000-00004
-
Costa e Silva JA N Alvarez G Mazzotti WF Gattaz J Ospina V Larach S Starkstein D Oliva L Cousins M Tohen CC Taylor J Wang PV Tran 2001 Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America J Clin Psychopharm 21 375 381 10.1097/00004714-200108000-00004 (Pubitemid 32673026)
-
(2001)
Journal of Clinical Psychopharmacology
, vol.21
, Issue.4
, pp. 375-381
-
-
Costa E Silva, J.A.1
Alvarez, N.2
Mazzotti, G.3
Gattaz, W.F.4
Ospina, J.5
Larach, V.6
Starkstein, S.7
Oliva, D.8
Cousins, L.9
Tohen, M.10
Taylor, C.C.11
Wang, J.12
Tran, P.V.13
-
18
-
-
23744432102
-
Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: Population-based study
-
DOI 10.1192/bjp.187.2.137
-
S Park D Ross-Degnan AS Adams J Sabin P Kanavos SB Soumerai 2005 Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia Br J Psychiatry 187 137 142 10.1192/bjp.187.2.137 16055824 (Pubitemid 41139685)
-
(2005)
British Journal of Psychiatry
, vol.187
, Issue.AUG.
, pp. 137-142
-
-
Park, S.1
Ross-Degnan, D.2
Adams, A.S.3
Sabin, J.4
Kanavos, P.5
Soumerai, S.B.6
-
19
-
-
40949136198
-
Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia. A systematic review
-
10.1097/JCP.0b013e318166c4d5
-
K Gao DE Kemp SJ Ganocy P Gajwani G Xia JR Calabrese 2008 Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia. A systematic review J Clin Psychopharm 28 203 209 10.1097/JCP.0b013e318166c4d5
-
(2008)
J Clin Psychopharm
, vol.28
, pp. 203-209
-
-
Gao, K.1
Kemp, D.E.2
Ganocy, S.J.3
Gajwani, P.4
Xia, G.5
Calabrese, J.R.6
-
20
-
-
0034116158
-
Prevalence of spontaneous dyskinesia in schizophrenia
-
10739325
-
WS Fenton 2000 Prevalence of spontaneous dyskinesia in schizophrenia J Clin Psychiatry 61 Suppl 4 10 14 10739325
-
(2000)
J Clin Psychiatry
, vol.61
, Issue.SUPPL 4
, pp. 10-14
-
-
Fenton, W.S.1
-
21
-
-
18844449208
-
Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness
-
DOI 10.1177/0269881105051539
-
WG Honer LC Kopala J Rabinowitz 2005 Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness J Psychopharmacol 19 3 277 285 10.1177/0269881105051539 1:CAS:528:DC%2BD2MXltlWju74%3D 15888513 (Pubitemid 40694946)
-
(2005)
Journal of Psychopharmacology
, vol.19
, Issue.3
, pp. 277-285
-
-
Honer, W.G.1
Kopala, L.C.2
Rabinowitz, J.3
-
23
-
-
50849107618
-
How CATIE brought us back to Kansas: A critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia
-
10.1192/apt.bp.107.003970
-
DC Owens 2008 How CATIE brought us back to Kansas: a critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia Adv Psychiatr Treat 14 17 28 10.1192/apt.bp.107. 003970
-
(2008)
Adv Psychiatr Treat
, vol.14
, pp. 17-28
-
-
Owens, D.C.1
-
24
-
-
58049157203
-
Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis
-
10.1016/S0140-6736(08)61764-X 1:CAS:528:DC%2BD1MXht1Wqsw%3D%3D 19058842
-
S Leucht C Corves D Arbter RR Engel C Li JM Davis 2009 Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Lancet 373 31 41 10.1016/S0140-6736(08)61764-X 1:CAS:528:DC%2BD1MXht1Wqsw%3D%3D 19058842
-
(2009)
Lancet
, vol.373
, pp. 31-41
-
-
Leucht, S.1
Corves, C.2
Arbter, D.3
Engel, R.R.4
Li, C.5
Davis, J.M.6
|